sameAs
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degenerationAge-Related Macular Degeneration: Advances in Management and DiagnosisPhotoreceptor cell death and rescue in retinal detachment and degenerationsCharacterization of a spontaneous retinal neovascular mouse modelA Novel ImageJ Macro for Automated Cell Death Quantitation in the RetinaAminoimidazole carboxamide ribonucleotide (AICAR) inhibits the growth of retinoblastoma in vivo by decreasing angiogenesis and inducing apoptosisUtilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularizationCytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularizationThe pathogenesis of choroidal neovascularization in patients with age-related macular degeneration.Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.Photodynamic therapy induces caspase-dependent apoptosis in rat CNV model.Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiologyExpression of pigment epithelium-derived factor in experimental choroidal neovascularization.Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization.Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.Photodynamic therapy: the nurse's role.Localization of rose bengal, aluminum phthalocyanine tetrasulfonate, and chlorin e6 in the rabbit eye.Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid.Investigating the effect of ciliary body photodynamic therapy in a glaucoma mouse model.Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture.Characterization of cytokine responses to retinal detachment in rats.Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma.Photodynamic therapy and combination treatments.Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis.Reduced photoreceptor damage after photodynamic therapy through blockade of nitric oxide synthase in a model of choroidal neovascularization.Endogenous endostatin inhibits choroidal neovascularization.The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.In vivo imaging of endothelial injury in choriocapillaris during endotoxin-induced uveitis.DNA sequence variants in the LOXL1 gene are associated with pseudoexfoliation glaucoma in a U.S. clinic-based population with broad ethnic diversityIncreased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1.Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization.The NEI/NCBI dbGAP database: genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degenerationSpectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degenerationHigher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).Review of the ocular angiogenesis animal models.Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach
P50
Q24622351-B79E6C9C-E99F-43CE-93FF-AA8FDC497B33Q26799617-59B71C99-921A-4C51-A427-5F81DBCB95E1Q26853192-CD69CC9A-B8F2-4474-A3B0-162775146B2EQ27312714-23834F05-272B-4D3D-9AF4-BD9000B04D36Q28364484-0328DE1C-0AC7-44F5-99DD-311A4BFBF017Q28484822-7C1E92E2-EB46-4FB3-9E34-73C07E9ADF82Q28740612-432ED89E-71BF-40E2-ABCD-B7EF615CC157Q30583016-47545E79-AAF8-4DED-959C-C8546BB663C1Q30813172-EA79DBD8-4647-4F70-9BCE-498F23ABAE48Q30824036-91ABFC4A-2A37-41D4-B88F-8C798C42333CQ30834562-B7C8CC8A-9F50-49EC-BD24-386D1E801F5FQ31037299-3347012C-6BF5-495A-929A-2F5486057E03Q31050171-6F567DEF-1169-4BE1-9C87-40685725E94BQ31092413-BCD1CC5D-0F48-4ABD-9E2B-570FB40649EFQ31143209-55B7AF7E-A2AC-4A69-9097-3703D6656256Q31159201-BBCA1F8F-E73D-4F8E-A2BE-4634AC757AF8Q31172091-464D94AE-0FAE-41FE-9B9A-0B415F543002Q31411189-A5FCC5A0-D36B-4F43-89F4-C3FD66A39F54Q31928181-AF557B77-79D3-4B65-926E-F88D430F93C7Q32065535-BF1A68D6-4A9B-4EAB-85EC-B2F9E82D3F7DQ33230548-27D23886-55D3-48E7-A753-8A6C18CD09A0Q33244631-AEBB094B-BAFE-42B0-ACC1-D7BBC995AE7CQ33244634-598A75E8-E0A5-4C93-A413-5B22D6FEDC97Q33249491-6577D864-20C1-45EC-ACC6-E048F9C0C7E2Q33254385-C9471AF4-A9DD-4197-A4A3-3C29A11B3692Q33265694-CF9FE91C-8DA5-4D1C-B2B4-FCEAC66D52ABQ33269760-3ECA1405-62FC-4A50-90EA-DED9535AEF8BQ33280756-907C71C3-ECF4-462E-A5C9-B5BE0928F820Q33282835-F0CBAA45-23D3-4AAD-8F7E-0BFBDFC73ECFQ33285816-0FC7B219-B576-40E4-A7CA-1D47965D1957Q33300538-F0C2E1CA-6776-4C97-AEBC-903CA09C9426Q33316269-15AA9E46-FAAF-4A8C-8B56-83DAACC1E748Q33318569-9E475ED7-0E79-416B-A489-9C0E0179A6F4Q33320965-3057026E-5AA1-42D5-9F0B-CED7A0B63F69Q33329067-EFD85416-9379-49EB-BDF2-97956A290D57Q33341495-619E05B7-E257-4DCE-9309-98103BDD6467Q33359481-9EA9A0B1-6E58-4F3D-9276-26EE1223A5E4Q33416828-EE521613-A602-423B-BABE-738C810BE9DAQ33431314-F36B77FB-6188-4763-B50E-DAE33B7852CFQ33507197-3D7396F6-CA02-4DD5-A6F7-8E358AF975F0
P50
description
Canadian ophthalmologist
@en
Canadian ophthalmologist
@en-ca
Canadian ophthalmologist
@en-gb
Universitaire et ophtalmologis ...... ale de médecine des États-Unis
@fr
academicus
@nl
oftalmóloga canadiense
@es
հետազոտող
@hy
طبيبة عيون كندية
@ar
name
Joan Miller
@af
Joan Miller
@an
Joan Miller
@ast
Joan Miller
@bar
Joan Miller
@bm
Joan Miller
@br
Joan Miller
@ca
Joan Miller
@co
Joan Miller
@cs
Joan Miller
@cy
type
label
Joan Miller
@af
Joan Miller
@an
Joan Miller
@ast
Joan Miller
@bar
Joan Miller
@bm
Joan Miller
@br
Joan Miller
@ca
Joan Miller
@co
Joan Miller
@cs
Joan Miller
@cy
altLabel
Joan W Miller
@ast
Joan W Miller
@en
Joan W Miller
@es
Joan W Miller
@nl
Joan W. Miller
@en
Joan Whitten Miller
@en
prefLabel
Joan Miller
@af
Joan Miller
@an
Joan Miller
@ast
Joan Miller
@bar
Joan Miller
@bm
Joan Miller
@br
Joan Miller
@ca
Joan Miller
@co
Joan Miller
@cs
Joan Miller
@cy
P106
P108
P1006
P1015
P214
P227
P244
P268
P269
P1006
P101
P1015
P1207
n2008147933
P19
P21
P213
0000 0001 1655 7645